These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 8248926)

  • 1. CYP4B1 activates 4-ipomeanol in rat lung.
    Verschoyle RD; Philpot RM; Wolf CR; Dinsdale D
    Toxicol Appl Pharmacol; 1993 Dec; 123(2):193-8. PubMed ID: 8248926
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytochrome P450 2B isoenzymes are responsible for the pulmonary bioactivation and toxicity of butylated hydroxytoluene, O,O,S-trimethylphosphorothioate and methylcyclopentadienyl manganese tricarbonyl.
    Verschoyle RD; Wolf CR; Dinsdale D
    J Pharmacol Exp Ther; 1993 Aug; 266(2):958-63. PubMed ID: 8355217
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition and induction of cytochrome P450 isoenzymes in rat lung.
    Verschoyle RD; Dinsdale D; Wolf CR
    J Pharmacol Exp Ther; 1993 Apr; 265(1):386-91. PubMed ID: 8474020
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The relationship between the catalytic activities of rabbit pulmonary cytochrome P-450 isozymes and the lung-specific toxicity of the furan derivative, 4-ipomeanol.
    Wolf CR; Statham CN; McMenamin MG; Bend JR; Boyd MR; Philpot RM
    Mol Pharmacol; 1982 Nov; 22(3):738-44. PubMed ID: 7155130
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 1-Nitronaphthalene toxicity in rat lung and liver: effects of inhibiting and inducing cytochrome P450 activity.
    Verschoyle RD; Carthew P; Wolf CR; Dinsdale D
    Toxicol Appl Pharmacol; 1993 Oct; 122(2):208-13. PubMed ID: 8212003
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro studies on the metabolic activation of the pulmonary toxin, 4-ipomeanol, by rat lung and liver microsomes.
    Boyd MR; Burka LT; Wilson BJ; Sasame HA
    J Pharmacol Exp Ther; 1978 Dec; 207(3):677-86. PubMed ID: 32381
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protection against chemical-induced lung injury by inhibition of pulmonary cytochrome P-450.
    Verschoyle RD; Dinsdale D
    Environ Health Perspect; 1990 Apr; 85():95-100. PubMed ID: 2384072
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renal toxicity due to reactive metabolites formed in situ in the kidney: investigations with 4-ipomeanol in the mouse.
    Boyd MR; Dutcher JS
    J Pharmacol Exp Ther; 1981 Mar; 216(3):640-6. PubMed ID: 7205642
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of isozyme-specific inhibition of cytochrome P450IIB1 activity in m-xylene-induced alterations in rat pulmonary benzo(a)pyrene metabolism.
    Stickney JA; Silverman DM; Schatz RA
    Xenobiotica; 1991 May; 21(5):641-9. PubMed ID: 1949897
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolism of ethyl carbamate by pulmonary cytochrome P450 and carboxylesterase isozymes: involvement of CYP2E1 and hydrolase A.
    Forkert PG; Lee RP
    Toxicol Appl Pharmacol; 1997 Oct; 146(2):245-54. PubMed ID: 9344892
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Generation and characterization of a Cyp4b1 null mouse and the role of CYP4B1 in the activation and toxicity of Ipomeanol.
    Parkinson OT; Liggitt HD; Rettie AE; Kelly EJ
    Toxicol Sci; 2013 Aug; 134(2):243-50. PubMed ID: 23748241
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of carbon monoxide on the cytochrome P-450-mediated activation of 4-ipomeanol by the isolated perfused rabbit lung.
    Trela BA; Carlson GP; Turek J; Rebar A; Mathews JM
    J Toxicol Environ Health; 1989; 27(3):341-50. PubMed ID: 2754758
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 4-Ipomeanol and 2-aminoanthracene cytotoxicity in C3H/10T1/2 cells expressing rabbit cytochrome P450 4B1.
    Smith PB; Tiano HF; Nesnow S; Boyd MR; Philpot RM; Langenbach R
    Biochem Pharmacol; 1995 Nov; 50(10):1567-75. PubMed ID: 7503758
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The in vitro formation of glutathione conjugates with the microsomally activated pulmonary bronchiolar aklylating agent and cytotoxin, 4-ipomeanol.
    Buckpitt AR; Boyd MR
    J Pharmacol Exp Ther; 1980 Oct; 215(1):97-103. PubMed ID: 7452496
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined radiation and cytochrome CYP4B1/4-ipomeanol gene therapy using the EGR1 promoter.
    Hsu H; Rainov NG; Quinones A; Eling DJ; Sakamoto KM; Spear MA
    Anticancer Res; 2003; 23(3B):2723-8. PubMed ID: 12894565
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differences in cytochrome P450-mediated biotransformation of 1,2-dichlorobenzene by rat and man: implications for human risk assessment.
    Hissink AM; Oudshoorn MJ; Van Ommen B; Haenen GR; Van Bladeren PJ
    Chem Res Toxicol; 1996 Dec; 9(8):1249-56. PubMed ID: 8951226
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Covalent binding of metabolites of 4-ipomeanol to rabbit pulmonary and hepatic microsomal proteins and to the enzymes of the pulmonary cytochrome P-450-dependent monooxygenase system.
    Slaughter SR; Statham CN; Philpot RM; Boyd MR
    J Pharmacol Exp Ther; 1983 Jan; 224(1):252-7. PubMed ID: 6848746
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bioactivation of 4-ipomeanol by CYP4B1: adduct characterization and evidence for an enedial intermediate.
    Baer BR; Rettie AE; Henne KR
    Chem Res Toxicol; 2005 May; 18(5):855-64. PubMed ID: 15892579
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo studies on the relationship between target organ alkylation and the pulmonary toxicity of a chemically reactive metabolite of 4-ipomeanol.
    Boyd MR; Burka LT
    J Pharmacol Exp Ther; 1978 Dec; 207(3):687-97. PubMed ID: 731424
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanism-based inactivation of mouse hepatic cytochrome P4502B enzymes by amine metabolites of musk xylene.
    Lehman-McKeeman LD; Johnson DR; Caudill D; Stuard SB
    Drug Metab Dispos; 1997 Mar; 25(3):384-9. PubMed ID: 9172959
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.